Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
A randomized clinical trial that treats vitiligo patients with oral vitamin D and Narrow-Band
Ultraviolet B (NB-UVB) phototherapy (intervention group); or placebo and NB-UVB phototherapy
(control group). We will evaluate if the group supplemented with vitamin D achieves a higher
repigmentation rate than the control group, proving the relevance of vitamin D as an
immunomodulator in the pathophysiology of vitiligo. These findings may support the use of
vitamin D as an economic, safe, and adjuvant treatment for vitiligo.